Atlas Trials

Registry Study of Revcovi Treatment in Patients With ADA-SCID

Clinical trial NCT03878069 · COMPLETED

Trial details

NCT number
NCT03878069
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Study type
OBSERVATIONAL
Adenosine Deaminase Severe Combined Immunodeficiency
Start date
2019-09-30
Primary completion
2023-01-18
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.